165 related articles for article (PubMed ID: 26491079)
1. PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2.
Witney TH; James ML; Shen B; Chang E; Pohling C; Arksey N; Hoehne A; Shuhendler A; Park JH; Bodapati D; Weber J; Gowrishankar G; Rao J; Chin FT; Gambhir SS
Sci Transl Med; 2015 Oct; 7(310):310ra169. PubMed ID: 26491079
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Glycolytic Response to Multiple Classes of Anti-glioblastoma Drugs by Noninvasive Measurement of Pyruvate Kinase M2 Using [
Beinat C; Patel CB; Xie Y; Gambhir SS
Mol Imaging Biol; 2020 Feb; 22(1):124-133. PubMed ID: 30989436
[TBL] [Abstract][Full Text] [Related]
3. Development of [
Beinat C; Alam IS; James ML; Srinivasan A; Gambhir SS
Mol Imaging Biol; 2017 Oct; 19(5):665-672. PubMed ID: 28236227
[TBL] [Abstract][Full Text] [Related]
4. A Clinical PET Imaging Tracer ([
Beinat C; Patel CB; Haywood T; Murty S; Naya L; Castillo JB; Reyes ST; Phillips M; Buccino P; Shen B; Park JH; Koran MEI; Alam IS; James ML; Holley D; Halbert K; Gandhi H; He JQ; Granucci M; Johnson E; Liu DD; Uchida N; Sinha R; Chu P; Born DE; Warnock GI; Weissman I; Hayden-Gephart M; Khalighi M; Massoud TF; Iagaru A; Davidzon G; Thomas R; Nagpal S; Recht LD; Gambhir SS
Clin Cancer Res; 2021 Dec; 27(23):6467-6478. PubMed ID: 34475101
[TBL] [Abstract][Full Text] [Related]
5. The Utility of [
Beinat C; Haywood T; Chen YS; Patel CB; Alam IS; Murty S; Gambhir SS
Mol Imaging Biol; 2018 Dec; 20(6):1015-1024. PubMed ID: 29736561
[TBL] [Abstract][Full Text] [Related]
6. A short review on cross-link between pyruvate kinase (PKM2) and Glioblastoma Multiforme.
Verma H; Cholia RP; Kaur S; Dhiman M; Mantha AK
Metab Brain Dis; 2021 Jun; 36(5):751-765. PubMed ID: 33651273
[TBL] [Abstract][Full Text] [Related]
7. Evidence That Does Not Support Pyruvate Kinase M2 (PKM2)-catalyzed Reaction as a Rate-limiting Step in Cancer Cell Glycolysis.
Xie J; Dai C; Hu X
J Biol Chem; 2016 Apr; 291(17):8987-99. PubMed ID: 26917721
[TBL] [Abstract][Full Text] [Related]
8. The Warburg effect in 2012.
Bayley JP; Devilee P
Curr Opin Oncol; 2012 Jan; 24(1):62-7. PubMed ID: 22123234
[TBL] [Abstract][Full Text] [Related]
9. Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.
Wolf A; Agnihotri S; Munoz D; Guha A
Neurobiol Dis; 2011 Oct; 44(1):84-91. PubMed ID: 21726646
[TBL] [Abstract][Full Text] [Related]
10. Development of [
Kendirli MT; Malek R; Silveira MB; Acosta C; Zhang S; Azevedo C; Nagy SC; Habte F; James ML; Recht LD; Beinat C
Nucl Med Biol; 2023; 124-125():108382. PubMed ID: 37634399
[TBL] [Abstract][Full Text] [Related]
11. Targeting Pyruvate Kinase M2 and Hexokinase II, Pachymic Acid Impairs Glucose Metabolism and Induces Mitochondrial Apoptosis.
Miao G; Han J; Zhang J; Wu Y; Tong G
Biol Pharm Bull; 2019 Jan; 42(1):123-129. PubMed ID: 30381614
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate kinase M2 and cancer: an updated assessment.
Iqbal MA; Gupta V; Gopinath P; Mazurek S; Bamezai RN
FEBS Lett; 2014 Aug; 588(16):2685-92. PubMed ID: 24747424
[TBL] [Abstract][Full Text] [Related]
13. Increased M2 Isoform of Pyruvate Kinase in Fibroblasts Contributes to the Growth, Aggressiveness, and Osteoclastogenesis of Odontogenic Keratocysts.
Zou Y; Wang R; Zhao J; Cai Y; Zhong W
Am J Pathol; 2021 May; 191(5):857-871. PubMed ID: 33640318
[TBL] [Abstract][Full Text] [Related]
14. Adaptations of energy metabolism during cerebellar neurogenesis are co-opted in medulloblastoma.
Tech K; Deshmukh M; Gershon TR
Cancer Lett; 2015 Jan; 356(2 Pt A):268-72. PubMed ID: 24569090
[TBL] [Abstract][Full Text] [Related]
15. Pyruvate kinase: Function, regulation and role in cancer.
Israelsen WJ; Vander Heiden MG
Semin Cell Dev Biol; 2015 Jul; 43():43-51. PubMed ID: 26277545
[TBL] [Abstract][Full Text] [Related]
16. Pyruvate kinase M2 regulates fibrosis development and progression by controlling glycine auxotrophy in myofibroblasts.
Satyanarayana G; Turaga RC; Sharma M; Wang S; Mishra F; Peng G; Deng X; Yang J; Liu ZR
Theranostics; 2021; 11(19):9331-9341. PubMed ID: 34646373
[No Abstract] [Full Text] [Related]
17. Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer.
Chao TK; Huang TS; Liao YP; Huang RL; Su PH; Shen HY; Lai HC; Wang YC
PLoS One; 2017; 12(7):e0182166. PubMed ID: 28753677
[TBL] [Abstract][Full Text] [Related]
18. Nonmetabolic functions of pyruvate kinase isoform M2 in controlling cell cycle progression and tumorigenesis.
Lu Z
Chin J Cancer; 2012 Jan; 31(1):5-7. PubMed ID: 22200182
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells.
Zhou CF; Li XB; Sun H; Zhang B; Han YS; Jiang Y; Zhuang QL; Fang J; Wu GH
IUBMB Life; 2012 Sep; 64(9):775-82. PubMed ID: 22807066
[TBL] [Abstract][Full Text] [Related]
20. A review on the emerging roles of pyruvate kinase M2 in anti-leukemia therapy.
Yang GJ; Wu J; Leung CH; Ma DL; Chen J
Int J Biol Macromol; 2021 Dec; 193(Pt B):1499-1506. PubMed ID: 34740687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
